BioCentury
ARTICLE | Clinical News

PCA regulatory update

October 1, 2001 7:00 AM UTC

Odyssey received U.S. Patent No. 6,294,330 covering the use of protein fragment complementation assays to identify and characterize protein-protein and drug-protein interactions in cells. The technolo...